NeoGenomics Inc (NEO)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -78,726 -77,728 -78,545 -84,234 -87,968 -96,329 -114,665 -125,637 -144,250 -163,322 -146,818 -35,642 -8,348 48,828 71,733 -10,964 4,172 -4,949 -5,363 3,452
Revenue (ttm) US$ in thousands 660,566 644,118 628,248 610,663 591,643 574,796 551,624 529,779 509,728 496,755 489,313 485,965 484,329 484,594 488,698 453,951 444,448 425,319 404,547 419,283
Net profit margin -11.92% -12.07% -12.50% -13.79% -14.87% -16.76% -20.79% -23.71% -28.30% -32.88% -30.00% -7.33% -1.72% 10.08% 14.68% -2.42% 0.94% -1.16% -1.33% 0.82%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-78,726K ÷ $660,566K
= -11.92%

Net profit margin, a key financial ratio, reflects the percentage of revenue that translates into net income after accounting for all expenses. NeoGenomics Inc's net profit margin has exhibited significant fluctuations over the periods provided in the data.

The trend shows a decline from positive figures in March 2020 and December 2020 to negative values in subsequent periods. In June 2021 and September 2021, the net profit margin significantly improved, indicating a strong profitability. However, this improvement was followed by a sharp decline in subsequent periods, reaching double-digit negative percentages in September 2022 to June 2024.

The negative net profit margins in recent periods may raise concerns about the company's ability to control costs and generate sustainable profits. Further analysis of the company's financial performance and cost structure is recommended to understand the underlying reasons for the deteriorating net profit margins.